Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation

被引:46
作者
Nave, H
Bedoui, S
Moenter, F
Steffens, J
Felies, M
Gebhardt, T
Straub, RH
Pabst, R
Dimitrijevic, M
Stanojevic, S
von Hörsten, S
机构
[1] Hannover Med Sch, Dept Funct & Appl Anat, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany
[3] Univ Regensburg, Med Ctr, Dept Internal Med 1, D-8400 Regensburg, Germany
[4] Inst Immunol & Virol Torlak, Immun Res Ctr Branislav Jankov, Belgrade, Serbia Monteneg, Serbia
关键词
monocytes/macrophages; rodent; endotoxic shock; cell trafficking; lung;
D O I
10.1016/j.jneuroim.2004.05.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neuropeptide Y (NPY) increases survival in experimental septic shock, which might be mediated by cardiovascular and/or immunological effects. To study the latter hypothesis, we monitored blood leukocyte subsets over 96 h after intravenous (i.v.) application of LPS in chronically i.v.-cannulated rats. LPS induced a dramatic leukopenia at 4 h after challenge, which was blunted in NPY-treated animals by stabilizing granulocyte and T-lymphocyte numbers. In addition, NPY treatment prevented tissue immigration of monocytes at early time points and consecutively mobilized activated monocytes from the third day after challenge. RT-PCR and in vitro adhesion studies provided evidence for a NPY Y-2 receptor-mediated effect on monocytes. Thus, NPY treatment has profound receptor-specific effects on the migration and adhesion of leukocytes under endotoxemic conditions. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 35 条
[1]   CHANGES IN PLASMA-CONCENTRATIONS OF VASOACTIVE NEUROPEPTIDES IN PATIENTS WITH SEPSIS AND SEPTIC SHOCK [J].
ARNALICH, F ;
SANCHEZ, JF ;
MARTINEZ, M ;
JIMENEZ, M ;
LOPEZ, J ;
VAZQUEZ, JJ ;
HERNANZ, A .
LIFE SCIENCES, 1994, 56 (02) :75-81
[2]   NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo:: sympathetic co-transmission during leukocyte mobilization [J].
Bedoui, S ;
Lechner, S ;
Gebhardt, T ;
Nave, H ;
Beck-Sickinger, AG ;
Straub, RH ;
Pabst, R ;
von Hörsten, S .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 132 (1-2) :25-33
[3]   Relevance of Neuropeptide Y for the neuroimmune crosstalk [J].
Bedoui, S ;
Kawamura, N ;
Straub, RH ;
Pabst, R ;
Yamamura, T ;
von Hösten, S .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 134 (1-2) :1-11
[4]   Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis:: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo [J].
Bedoui, S ;
Miyake, S ;
Lin, YW ;
Miyamoto, K ;
Oki, S ;
Kawamura, N ;
Beck-Sickinger, A ;
von Hörsten, S ;
Yamamura, T .
JOURNAL OF IMMUNOLOGY, 2003, 171 (07) :3451-3458
[5]   Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood:: mobilization of B-1-like B-lymphocytes and activated monocytes [J].
Bedoui, S ;
Kuhlmann, S ;
Nave, H ;
Drube, J ;
Pabst, R ;
von Hörsten, S .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 117 (1-2) :125-132
[6]   Leukocytes: friend or foe [J].
Bellingan, G .
INTENSIVE CARE MEDICINE, 2000, 26 (Suppl 1) :S111-S118
[7]   Neurohormonal host defense in endotoxin shock [J].
Berczi, I .
NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 :787-802
[8]   Effect of neuropeptide Y on inflammatory paw edema in the rat:: involvement of peripheral NPYY1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26) [J].
Dimitrijevic, M ;
Stanojevic, S ;
Vujic, V ;
Kovacevic-Jovanovic, V ;
Beck-Sickinger, A ;
Demuth, HU ;
von Hörsten, S .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 129 (1-2) :35-42
[9]   AGAR ACCUMULATES IN RAT PERITONEAL-MACROPHAGES ELICITED WITH THIOGLYCOLLATE BROTH [J].
EICHNER, RD ;
SMEATON, TC .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1983, 18 (03) :259-263
[10]   The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y2 receptor:: Pharmacological evidence and molecular cloning [J].
Goumain, M ;
Voisin, T ;
Lorinet, AM ;
Ducroc, R ;
Tsocas, A ;
Rozé, C ;
Rouet-Benzineb, P ;
Herzog, H ;
Balasubramaniam, A ;
Laburthe, M .
MOLECULAR PHARMACOLOGY, 2001, 60 (01) :124-134